Related Experiment Video
Updated: May 15, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Stakeholders' Perspectives on Medication Adherence Enhancing Interventions.
Bijan J Borah1, Lisa J Pieretti2, Alan J Balch3
1Mayo Clinic College of Medicine and Science and the Kern Center for the Science of Health Care Delivery, Rochester, MN, USA.
Medication nonadherence affects 50% of patients, leading to adverse events and high costs. A systematic literature review found that while clinical outcomes are measured, economic and patient-reported outcomes need more focus for adherence interventions.
Area of Science:
- Health Economics
- Patient Adherence Research
- Healthcare Management
Background:
- Medication nonadherence presents a significant healthcare challenge with approximately 50% prevalence, leading to avoidable adverse events and substantial annual costs per person.
- The ISPOR Medication Adherence and Persistence Special Interest Group's 2023 systematic literature review (SLR) aimed to evaluate measures for assessing medication adherence enhancing interventions (MAEIs).
Purpose of the Study:
- To supplement SLR findings by presenting stakeholder perspectives on assessing MAEIs.
- To identify gaps in outcome measurement for MAEIs and propose future research directions.
Main Methods:
- Systematic literature review (SLR) conducted in 2023.
- Analysis of stakeholder perspectives (patients, manufacturers, providers, health technology assessment agencies, payers).
Main Results:
- The SLR revealed frequent measurement of medication adherence and clinical outcomes, but underexplored economic and patient-reported outcomes.
- Stakeholders emphasize the need for MAEIs to demonstrate improved clinical outcomes, quality of life, and cost savings.
- The SLR highlighted a need for consensus-based criteria for assessing MAEIs.
Conclusions:
- MAEIs require a comprehensive approach, incorporating personalized strategies based on socioeconomic factors and social needs.
- Future research should quantify MAEI implementation costs and stakeholder cost-bearing mechanisms for widespread adoption.
- Integrating artificial intelligence and patient-centered approaches is crucial for developing effective, personalized adherence strategies.
More Related Videos
Related Concept Videos
Drug Therapy
Antianxiety Medications
Stress Prevention and Stress Management Techniques VI
Motivation and Self-Determination
Motivation, the driving force behind behavior, plays a pivotal role at every stage of the change process. The research...
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Psychosis: Goals of Pharmacotherapy

